Dopamine receptor signaling and current and future antipsychotic drugs.
about
The role of α5 GABAA receptor agonists in the treatment of cognitive deficits in schizophreniaPeripheral and central effects of circulating catecholaminesUnique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in RatsPhenothiazine-derived antipsychotic drugs inhibit dynamin and clathrin-mediated endocytosis.Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic MiceThe role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue.Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorderStructure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors.Evidence for limited D1 and D2 receptor coexpression and colocalization within the dorsal striatum of the neonatal mouseLikelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: A comparison of genetic variants in two independent patient populations.Imaging the Biodistribution and Performance of Transplanted Stem Cells with PET.Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophreniaAntipsychotic-like actions of the satiety peptide, amylin, in ventral striatal regions marked by overlapping calcitonin receptor and RAMP-1 gene expression.Aripiprazole (ABILIFY MAINTENA®): a review of its use as maintenance treatment for adult patients with schizophrenia.Electrophysiological endophenotypes in rodent models of schizophrenia and psychosis.Crossreactivity of an Antiserum Directed to the Gram-Negative Bacterium Neisseria gonorrhoeae with the SNARE-Complex Protein Snap23 Correlates to Impaired Exocytosis in SH-SY5Y Cells.Electrophysiological characterization of dopamine neuronal activity in the ventral tegmental area across the light-dark cycle.Phosphodiesterase 1: A Unique Drug Target for Degenerative Diseases and Cognitive Dysfunction.A new nomenclature for classifying psychotropic drugs.Treatment of tardive dyskinesia with tetrabenazine or valbenazine: a systematic review.Altered subcellular distribution of the 75-kDa DISC1 isoform, cAMP accumulation, and decreased neuronal migration in schizophrenia and bipolar disorder: implications for neurodevelopment.Clinical Management of Antipsychotic-Induced Hyperprolactinemia.The Role of Cannabis within an Emerging Perspective on Schizophrenia
P2860
Q27026637-8B13CBAC-8BF0-4DBB-B548-BB30A164D123Q28255579-B4818C8B-166B-4B7A-AA21-773516FE1900Q28546441-84151279-F4D5-4362-924F-97C0DA3D1767Q30009226-8ECC82BC-CC3A-407A-BE18-5299D3E507B4Q30364693-B9847002-1A50-4C8C-BAC3-808E7805D0D2Q30437188-78A30F8D-3943-4E12-B0AE-0BA857FEB2DDQ30840162-84061364-0D2E-46FA-9456-0E67692F22E7Q34983219-F57265B7-F3FE-4EE7-9F39-9F11A69BB756Q35328013-A7856D79-DC71-4344-B97F-7402B8E5B0E6Q36806137-496FAF6B-9E31-4884-853E-ECD3087A22F0Q37230427-79D6BF98-DA19-40A2-9754-CF99D7C3FB7AQ37598278-E1FA7F83-2B58-484E-B63C-00FDBEBD2213Q37650208-B2F971B1-5FBA-42EF-8D47-A711911025C7Q38223569-43C2C401-52B1-4A05-BC7D-D1239596CFE8Q38440780-F2A09C5D-C511-4EFA-BDE2-0D75A8A0414BQ40230309-2C3B26EA-D365-4089-907E-30242D5C2983Q42461100-980C4844-B155-4198-814C-562304BF1A87Q42515895-65297E69-B81B-4CE4-9D6F-31CCE4CD12D2Q47750718-AC8833C4-FF9F-4C03-B1CA-01B889282221Q47753620-57E77887-374C-435D-8928-794F30BCA2A1Q48361051-CB0941C0-F200-4199-88C8-3DE35D2ECC18Q50593929-7FDD1384-B63B-4250-8E82-E5B9899E9167Q58794814-18109BDE-A4F2-429B-BCAC-C699781AA38C
P2860
Dopamine receptor signaling and current and future antipsychotic drugs.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Dopamine receptor signaling and current and future antipsychotic drugs.
@en
type
label
Dopamine receptor signaling and current and future antipsychotic drugs.
@en
prefLabel
Dopamine receptor signaling and current and future antipsychotic drugs.
@en
P2860
P1476
Dopamine receptor signaling and current and future antipsychotic drugs.
@en
P2093
Kevin N Boyd
Richard B Mailman
P2860
P356
10.1007/978-3-642-25761-2_3
P577
2012-01-01T00:00:00Z